Hohl Benjamin

CIK 00018827641 companyBOULDER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001882764

Recent Transactions

50 trades

Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-09-29$2.48/sh+3,250→ 26,250 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-09-29$20.40/sh−3,250→ 23,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-09-29−3,250→ 105,056 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-08-27$2.48/sh+3,250→ 26,250 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-08-27$20.63/sh−3,250→ 23,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-08-27−3,250→ 108,306 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-07-28$20.45/sh−3,185→ 23,065 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-07-28$21.30/sh−65→ 23,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-07-28−3,250→ 111,556 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-07-28$2.48/sh+3,250→ 26,250 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-07-10$2.48/sh+1,000→ 24,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-07-10−1,000→ 114,806 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-07-10$22.66/sh−1,000→ 23,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-06-27$21.66/sh−198→ 23,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-06-27−3,250→ 115,806 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-06-27$2.48/sh+3,250→ 26,250 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-06-27$20.86/sh−3,052→ 23,198 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-06-13$22.55/sh−3,000→ 23,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-06-13−3,000→ 119,056 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-06-13$2.48/sh+3,000→ 26,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-05-27$2.48/sh+3,250→ 26,250 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-05-27$16.18/sh−3,250→ 23,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-05-27−3,250→ 122,056 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-04-28$18.68/sh−3,181→ 23,069 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-04-28$2.48/sh+3,250→ 26,250 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-04-28−3,250→ 125,306 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-04-28$19.12/sh−69→ 23,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-03-27−3,250→ 128,556 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-03-27$21.33/sh−3,250→ 23,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-03-27$2.48/sh+3,250→ 26,250 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-03-24−1,000→ 131,806 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-03-24$2.48/sh+1,000→ 24,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-03-24$22.50/sh−1,000→ 23,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-03-04$2.48/sh+10,000→ 23,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-03-04−10,000→ 132,806 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-02-27$2.48/sh+3,250→ 16,250 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-02-27−3,250→ 142,806 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-02-27$20.41/sh−3,250→ 13,000 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-02-06+171,000→ 171,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-02-05$2.48/sh+1,000→ 14,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-02-05−1,000→ 146,056 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-02-05$22.52/sh−1,000→ 13,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-01-27$2.48/sh+3,250→ 16,250 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-01-27$21.59/sh−3,250→ 13,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-01-27−3,250→ 147,056 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-01-03$2.48/sh+1,000→ 14,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-01-03$25.04/sh−1,000→ 13,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-01-03−1,000→ 150,306 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-12-30−900→ 164,306 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-12-30$2.48/sh+900→ 900 total

Companies

Enliven Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
$ELVN

Recent Filings

Address

C/O ENLIVEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD

BOULDER, CO, 80301

View on SEC.gov